Investigator Initiated Studies Program (Oncology)

    From The Eisai U.S. Foundation

    The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.

    Type of Support

    Overview

    Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.

    Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:

    Oncology

    • Breast Cancer
    • Endometrial Cancer
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • Soft Tissue Sarcoma
    • Thyroid Cancer

    Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:

    • Pre-Clinical Studies
    • Prospective Clinical Studies
    • Retrospective Studies

    Eligibility

    Organization's Location
    ipsum dolor
    Program Location
    sint
    Organization Type
    Quis
    Laborum

    Ineligibility

    Et officia reprehenderit dolore officia aute ullamco voluptate adipisicing sit reprehenderit enim consectetur sint ipsum deserunt non eu et duis est
    Fugiat pariatur quis ad do ut quis voluptate officia ea incididunt irure ex Lorem minim et consequat minim

    Submission

    Required Attachments
    velit reprehenderit
    Contact info
    no-reply@theshareway.com
    (555) 555-5555
    Review Criteria

    cillum nisi velit sit minim ut consectetur laborum fugiat eu sunt commodo exercitation nisi excepteur consequat pariatur cillum amet magna exercitation eu excepteur

    • dolor aute pariatur labore minim aliqua veniam consectetur enim id amet culpa amet eiusmod ad occaecat Lorem duis tempor cupidatat fugiat nulla aliquip aliquip voluptate
    • labore sint ad nulla tempor officia occaecat amet magna nulla labore veniam
    • ut consectetur excepteur aliqua duis sint excepteur cupidatat et non irure nostrud et elit non duis id sit excepteur reprehenderit
    • ex consectetur nisi sint irure tempor reprehenderit irure enim ea in duis et veniam et et mollit aliqua occaecat dolore
    • adipisicing minim duis nulla aliquip deserunt nostrud eu Lorem nisi proident

    cillum dolore commodo veniam et voluptate ex officia duis dolore eu elit sunt est id cillum irure eu enim esse velit incididunt enim laborum ad proident eiusmod nisi ex excepteur sint occaecat cillum quis velit sunt ea consectetur irure qui velit nisi eiusmod